ISE Chemicals Corporation
Financial Summary for the Fiscal Year Ending December 2025 [Japanese GAAP] (Consolidated)
For the fiscal year ending December 2025, consolidated net sales were JPY 39,258 million (up 17.9% YoY), operating income was JPY 9,484 million (up 23.8% YoY), and net income attributable to owners of parent was JPY 6,498 million (up 28.1% YoY). A stock split of 1 share into 10 shares will be implemented on January 1, 2026.
Key Figures
- Net Sales: JPY 39,258 million (Up 17.9% YoY)
- Operating Income: JPY 9,484 million (Up 23.8% YoY)
- Net Income Attributable to Owners of Parent: JPY 6,498 million (Up 28.1% YoY)
AI要約
Overview of Business Performance
For the fiscal year ending December 2025, consolidated results showed net sales of JPY 39,258 million (up 17.9% YoY), operating income of JPY 9,484 million (up 23.8% YoY), ordinary income of JPY 9,252 million (up 24.4% YoY), and net income attributable to owners of parent of JPY 6,498 million (up 28.1% YoY). The iodine and natural gas business performed well, recording net sales of JPY 34,656 million (up 23.4% YoY) and operating income of JPY 9,465 million (up 22.2% YoY). Although net sales in the metal compounds business decreased to JPY 461 million (down 11.6% YoY), operating income improved to a positive JPY 18 million.
Financial Position and Dividend Status
Total assets amounted to JPY 51,015 million (an increase of JPY 5,764 million from the previous term), and net assets were JPY 40,070 million (up JPY 4,500 million). The equity ratio remains stable at 78.5%. Cash flow from operating activities was positive JPY 7,528 million, investing activities used JPY 6,692 million, and financing activities used JPY 2,023 million. The annual dividend was JPY 390 (up JPY 30 YoY). For the fiscal year ending December 2026, considering the stock split, a dividend of JPY 40 per share (equivalent to JPY 400 before the split) is forecasted.
